CLINICO-EPIDEMIOLOGICAL STUDY OF ENDOMETRIAL HYPERPLASIA – A RISK FACTOR FOR THE DEVELOPMENT OF ENDOMETRIAL CARCINOMA?
Abstract
Aim: Metaplasia is defined as a transformation of an adult epithelial or conjunctive cellular type into another adult cellular type. Endometrial hyperplasia and particularly complex atypical hyperplasia exposes to a high risk of development of the endometrial carcinoma, being considered a lesion precursory to the same. Endometrial hyperplasias are risk factors for the development of endometrial carcinoma and their prophylaxis implies their accurate diagnosis, taking into account that the adenocarcinomas diagnosed in an advanced stage, whose therapeutic context differs from the early stages, have a much lower chance of survival. Material and methods: Our study aimed at highlighting objective criteria in establishing the morphological diagnosis and in evaluating the prognostic elements. The studied batch included 875 patients with endometrial hyperplasia and 263 patients with endometrial adenocarcinoma, who were admitted between 2003 and 2007, and the histopathologic diagnosis was obtained by processing the hysterectomy pieces. The presence of this tumour was at its highest level half-way through the study, which was in 2005. Results: According to the study, there was a higher proportion of patients with endometrial carcinoma from the urban environment (58.2%) than the ones from the rural environment (only 41.8%). Depending on their age, most cases of endometrial adenocarcinoma were diagnosed in 53-year old patients, with an average age of 58.94 years. Our study, made of the two batches of endometrial adenocarcinomas, shows that between the endometrial and non-endometrial adenocarcinoma there are significant differences related to the patients’ age, the morphological aspect of the carcinoma, the architectural degree, the nuclear degree of tumours and the invasion in the myometrium. Conclusions: Our study proves that endometrial hyperplasia is a frequent diagnosis in peri- and postmenopausal patients and is frequently identified following investigations for an abnormal uterine bleeding. The age of patients with endometrial carcinoma is an important prognostic factor independent of other parameters. The difference between complex hyperplasia with no atypias and complex hyperplasia with atypias is important, because atypical complex hyperplasia is considered the precursor of endometrial adenocarcinoma.
References
2. Abeler VM. Aggressive Forms of Endometrial Carcinoma. Pathology of Endometrium. Short Courses. Pathol 1999; 417-418.
3. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial Cancer. Lancet 2005; 366: 491-505.
4. Baak JPA, Wisse-Brekelmans ECM, Fleege JC et al. Assessment of Risk of Endometrial Cancer in Hyperplasia, by Means of Morphologic and Morphometric Features. Pathol Res Pract 1992; 188: 856-859.
5. Bilgin T, Ozuysal S, Ozan H et al. Coexisting Endometrial Cancer in Patients with a Preoperative Diagnosis of Atypical Endometrial Hyperplasia. J Obstet Gynecol Res 2004; 30: 205
6. Brown J, Thumber S, Hricak H. MR Imaging of the Uterus: Low-Signal Intensity Abnormalities of the Endometrium and Endometrial Cavity. Magn Reson Imaging 1990; 8(3): 309-13.
7. Burke TW, Tortolero-Luna G, Malpica A. Endometrial Hyperplasia and Endometrial Cancer. Obstet Gynecol Clin North America 1996; 23: 411-456.
8. Clark TJ, Neelakantan D, Gupta JK. The Management of Endometrial Hyperplasia: An Evaluation of Current Practice. Eur J Obstet Gynecol Reprod Biol 2006; 125: 259-264.
9. Dumitru Daniela-Mihaela, Onofriescu M., Cărăuleanu A., Rădulescu Doiniţa. The Endovaginal Ultra-sound Findings of a Thin and Regular Endometrum Is Uncommon in Endometrial Cancer. Rev Med Chir Soc Med Nat Iasi 2009; 113(1): 132-135.
10. Horn LC, Schnurrbusch U, Bilek K, et al. Risk of Progression in Complex and Atypical Endometrial Hyperplasia: Clinicopathologic Analysis in Cases With and Without Progestogen Treatment. Int J Gynecol Cancer 2004; 14: 348-53.
11. Mincă DG, Marcu MG. Sănătate publică şi management sanitar, note de curs pentru învăţământul postuniversitar, ed. a II-a revizuită, Ed. Universitară „Carol Davila”, Bucharest, 2005.
12. Moss A, Gamsu G, Genant H. Computed Tomography of the Body with Magnetic Resonance Imaging Vol. Three: Abdomen and Pelvis. WB Saunders Co Philadelphia, 1992.
13. Pangal Alexandra, Costăchescu Gh., Aldea Marie Jeanne. Metodologia diagnosticului hiperplaziilor endometriale. Examen clinic, paraclinic şi management. Rev Med Chir Soc Med Nat Iasi 2010; 114(2): 445-449.
14. Pricop M. Oncologie ginecologică clinică, Polirom 2000: 159-160
15. Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2005. Cancer J Clin 2005; 55(1): 31-44.
Additional Files
Published
Issue
Section
License
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form